These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7633711)

  • 1. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group.
    Rand CS; Nides M; Cowles MK; Wise RA; Connett J
    Am J Respir Crit Care Med; 1995 Aug; 152(2):580-8. PubMed ID: 7633711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
    Anthonisen NR; Connett JE; Kiley JP; Altose MD; Bailey WC; Buist AS; Conway WA; Enright PL; Kanner RE; O'Hara P
    JAMA; 1994 Nov; 272(19):1497-505. PubMed ID: 7966841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nebulizer chronolog to monitor compliance with inhaler use.
    Tashkin DP; Rand C; Nides M; Simmons M; Wise R; Coulson AH; Li V; Gong H
    Am J Med; 1991 Oct; 91(4A):33S-36S. PubMed ID: 1951401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metered-dose inhaler adherence in a clinical trial.
    Rand CS; Wise RA; Nides M; Simmons MS; Bleecker ER; Kusek JW; Li VC; Tashkin DP
    Am Rev Respir Dis; 1992 Dec; 146(6):1559-64. PubMed ID: 1456575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study.
    Wise RA; Enright PL; Connett JE; Anthonisen NR; Kanner RE; Lindgren P; O'Hara P; Owens GR; Rand CS; Tashkin DP
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):866-72. PubMed ID: 9517604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
    Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC;
    Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog.
    Nides MA; Tashkin DP; Simmons MS; Wise RA; Li VC; Rand CS
    Chest; 1993 Aug; 104(2):501-7. PubMed ID: 8339641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
    Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.
    Scanlon PD; Connett JE; Waller LA; Altose MD; Bailey WC; Buist AS; Tashkin DP;
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):381-90. PubMed ID: 10673175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Dutch CNSLD Study Group.
    Brand PL; Kerstjens HA; Postma DS; Sterk PJ; Quanjer PH; Sluiter HJ; Dijkman JH; van Herwaarden CL; Hilvering C; Jansen HM
    Eur Respir J; 1992 Jan; 5(1):21-31. PubMed ID: 1533595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalizations and mortality in the Lung Health Study.
    Anthonisen NR; Connett JE; Enright PL; Manfreda J;
    Am J Respir Crit Care Med; 2002 Aug; 166(3):333-9. PubMed ID: 12153966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial.
    Simmons MS; Nides MA; Rand CS; Wise RA; Tashkin DP
    Chest; 1996 Apr; 109(4):963-8. PubMed ID: 8635378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.